細胞外マトリックスから見たケロイド

ケロイドは,細胞増殖が主体の腫瘍とは異なり,細胞外マトリックスの増殖を主体とした病変と考えられている。皮膚の細胞外マトリックスは,コラーゲン,ヒアルロン酸,プロテオグリカンが主体となっている。ケロイド病変部では,特徴的なコラーゲン線維の束やヒアルロン酸の分布が正常部とは異なることが報告されている。また,プロテオグリカンの構成成分であるグリコサミノグリカン(GAG)の過剰蓄積,弾性線維の減少・消失が報告されているが,ケロイドの病態形成との関連は,いまだ解明されていない。今後細胞外マトリックスの異常そのものが,どのようにケロイドの病態形成にかかわっているかを解明し,細胞外マトリックスの産生・代謝を...

Full description

Saved in:
Bibliographic Details
Published in創傷 Vol. 5; no. 2; pp. 51 - 55
Main Authors 磯貝, 善蔵, 貴志, 和生, 岡部, 圭介, 荒牧, 典子
Format Journal Article
LanguageJapanese
Published 一般社団法人 日本創傷外科学会 2014
Subjects
Online AccessGet full text
ISSN1884-880X
DOI10.11310/jsswc.5.51

Cover

Abstract ケロイドは,細胞増殖が主体の腫瘍とは異なり,細胞外マトリックスの増殖を主体とした病変と考えられている。皮膚の細胞外マトリックスは,コラーゲン,ヒアルロン酸,プロテオグリカンが主体となっている。ケロイド病変部では,特徴的なコラーゲン線維の束やヒアルロン酸の分布が正常部とは異なることが報告されている。また,プロテオグリカンの構成成分であるグリコサミノグリカン(GAG)の過剰蓄積,弾性線維の減少・消失が報告されているが,ケロイドの病態形成との関連は,いまだ解明されていない。今後細胞外マトリックスの異常そのものが,どのようにケロイドの病態形成にかかわっているかを解明し,細胞外マトリックスの産生・代謝を制御することで,ケロイド治療法の開発に発展していく可能性があると考えられる。
AbstractList ケロイドは,細胞増殖が主体の腫瘍とは異なり,細胞外マトリックスの増殖を主体とした病変と考えられている。皮膚の細胞外マトリックスは,コラーゲン,ヒアルロン酸,プロテオグリカンが主体となっている。ケロイド病変部では,特徴的なコラーゲン線維の束やヒアルロン酸の分布が正常部とは異なることが報告されている。また,プロテオグリカンの構成成分であるグリコサミノグリカン(GAG)の過剰蓄積,弾性線維の減少・消失が報告されているが,ケロイドの病態形成との関連は,いまだ解明されていない。今後細胞外マトリックスの異常そのものが,どのようにケロイドの病態形成にかかわっているかを解明し,細胞外マトリックスの産生・代謝を制御することで,ケロイド治療法の開発に発展していく可能性があると考えられる。
Author 荒牧, 典子
岡部, 圭介
磯貝, 善蔵
貴志, 和生
Author_xml – sequence: 1
  fullname: 磯貝, 善蔵
  organization: 独立行政法人国立長寿医療研究センター先端診療部皮膚科
– sequence: 1
  fullname: 貴志, 和生
  organization: 慶應義塾大学形成外科
– sequence: 1
  fullname: 岡部, 圭介
  organization: 慶應義塾大学形成外科
– sequence: 1
  fullname: 荒牧, 典子
  organization: 慶應義塾大学形成外科
BookMark eNo9j8tKAzEYhYMoWGtXPseMySSTZMCNFG9QcKPgLqS56Ay1yqQgLjvZWLp3WTfFhSAquPF5fsQ-hkXFxeHAx-GDs4FWh1dDh9AWwSkhlODtKoQbk-ZpTlZQi0jJEinx2TrqhFD2MWacSSpIC9Gv99dFnH3O7yHOIN5BfIIYoXmB5gPGU2gmi8cpjB-geYP4DM0c4mQTrXk9CK7z1210ur930j1MescHR93dXlJljOGEGcsx91bzzBcFNwUR2GKncU59PxPeCOykEHa5M5QLKq3lPGOWWsPzzHPaRju_3iqM9LlT13V5qetbpetRaQZO_XxUucqWyck_Nhe6VpWm33IgYYM
ContentType Journal Article
Copyright 2014 一般社団法人 日本創傷外科学会
Copyright_xml – notice: 2014 一般社団法人 日本創傷外科学会
DOI 10.11310/jsswc.5.51
DatabaseTitleList
DeliveryMethod fulltext_linktorsrc
EISSN 1884-880X
EndPage 55
ExternalDocumentID article_jsswc_5_2_5_51_article_char_ja
GroupedDBID ALMA_UNASSIGNED_HOLDINGS
JSF
KQ8
RJT
ID FETCH-LOGICAL-j2440-4cd606fda62f996c9170d0ea053fb27fc70e877d4cdc36738dd6624d3dc652f63
IngestDate Wed Sep 03 06:31:02 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Issue 2
Language Japanese
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-j2440-4cd606fda62f996c9170d0ea053fb27fc70e877d4cdc36738dd6624d3dc652f63
OpenAccessLink https://www.jstage.jst.go.jp/article/jsswc/5/2/5_51/_article/-char/ja
PageCount 5
ParticipantIDs jstage_primary_article_jsswc_5_2_5_51_article_char_ja
PublicationCentury 2000
PublicationDate 20140000
PublicationDateYYYYMMDD 2014-01-01
PublicationDate_xml – year: 2014
  text: 20140000
PublicationDecade 2010
PublicationTitle 創傷
PublicationTitleAlternate 創傷
PublicationYear 2014
Publisher 一般社団法人 日本創傷外科学会
Publisher_xml – name: 一般社団法人 日本創傷外科学会
References 20) Sible JC, Retting WJ, Eriksson E, et al : Gene expression of tenascin is altered in normal scars and keloids. Wound Repair Regen, 1995 ; 3 : 37-48.
11) Phan TT, Lim IJ, Aalami O, et al : Smad3 signaling plays an important role in keloid pathogenesis via epithelial-mesenchymal interaction. J Pathol, 2005 ; 207 : 232-42.
4) Luo S, Benathan M, Raffoul W, et al : Abnormal balance between proliferation and apoptotic cell death in fibroblasts derived from keloid lesions. Plast Reconstr Surg, 2001 ; 107 : 87-96.
14) Ikeda M, Naitoh M, Kubota H, et al : Elastic fiber assembly is disrupted by excessive accumulation of chondroitin sulfate in the human dermal fibrotic disease, keloid. Biochem Biophys Res Commun, 2009 ; 390 : 1221-8.
3) Chodon T, Sugihara T, Igawa HH, et al : Keloid-derived fibroblasts are refractory to Fas-mediated apoptosis and neutralization of autocrine transforming growth factor-β1 can abrogate this resistance. Am J Pathol, 2000 ; 157 : 1661-9.
9) Ulrich D, Ulrich F, Unglaub F, et al : Matrix metalloproteinases and tissue inhibitors of metalloproteinases in patients with different types of scars and keloids. J Plast Reconstr Aesthet Surg, 2010 ; 63 : 1015-21.
1) Smith LT, Holbrook KA, Madri JA : Collagen types I, III, and V in human embryonic and fetal skin. Am J Anat, 1986; 175 : 507-21.
24) 荒牧典子, 磯貝善蔵, 岡部圭介, ほか : ケロイド組織における細胞外マトリックスの産生・分解. 瘢痕・ケロイド治療ジャーナル, 2013 ; 7 : 5-7.
25) Honardoust D, Eslami A, Larjava H, et al : Localization of small leucine-rich proteoglycans and transforming growth factor-beta in human oral mucosal wound healing. Wound Repair Regen, 2008 ; 16 : 814-23.
5) Sasaki T, Majamaa K, Uitto J : Reduction of collagen production in keloid fibroblast cultures by ethyl-3, 4-dihydroxybenzoate. Inhibition of prolyl hydroxylase activity as a mechanism of action. J Biol Chem, 1987 ; 262 : 9397-403.
8) Neely AN, Clendening CE, Gardner J, et al : Gelatinase activity in keloids and hypertrophic scars. Wound Repair Regen, 1999 ; 7 : 166-71.
13) Meyer LJ, Russell SB, Russell JD, et al : Reduced hyaluronan in keloid tissue and cultured keloid fibroblasts. J Invest Dermatol, 2000 ; 114 : 953-9.
21) Yagi Y, Muroga E, Naitoh M, et al : An ex vivo model employing keloid-derived cell-seeded collagen sponges for therapy development. J Invest Dermatol, 2013 ; 133 : 386-93.
15) Amadeu TP, Braune AS, Porto LC, et al : Fibrillin-1 and elastin are differentially expressed in hypertrophic scars and keloids. Wound Repair Regen, 2004 ; 12 : 169-74.
26) Meenakshi J, Vidyameenakshi S, Ananthram D, et al : Low decorin expression along with inherent activation of ERK1, 2 in ear lobe keloids. Burns, 2009 ; 35 : 519-26.
23) Enomoto H, Nelson CM, Somerville RP, et al : Cooperation of two ADAMTS metalloproteases in closure of the mouse palate identifies a requirement for versican proteolysis in regulating palatal mesenchyme proliferation. Development, 2010 ; 137 : 4029-38.
7) Khasigov PZ, Podobed OV, Ktzoeva SA, et al : Matrix metalloproteinases of normal human tissues. Biochemistry (Mosc), 2001 ; 66 : 130-40.
16) Babu M, Diegelmann R, Oliver N : Fibronectin is overproduced by keloid fibroblasts during abnormal wound healing. Mol Cell Biol, 1989 ; 9 : 1642-50.
2) Bran GM, Goessler UR, Hormann K, et al : Keloids : Current concepts of pathogenesis (review). Int J Mol Med, 2009 ; 24 : 283-93.
12) Meran S, Thomas DW, Stephens P, et al : Hyaluronan facilitates transforming growth factor-beta1-mediated fibroblast proliferation. J Biol Chem, 2008 ; 283 : 6530-45.
17) Kischer CW, Hendrix MJ : Fibronectin (FN) in hypertrophic scars and keloids. Cell Tissue Res, 1983 ; 231 : 29-37.
10) Aoki M, Miyake K, Ogawa R, et al : siRNA Knockdown of Tissue Inhibitor of Metalloproteinase-1 in Keloid Fibroblasts Leads to Degradation of Collagen Type I. J Invest Dermatol, 2013 Sep 16. doi : 10. 1038/jid. 2013. 396.
18) Kischer CW, Wagner HN Jr, Pindur J, et al : Increased fibronectin production by cell lines from hypertrophic scar and keloid. Connect Tissue Res, 1989 ; 23 : 279-88.
22) McCulloch DR, Nelson CM, Dixon LJ, et al : ADAMTS metalloproteases generate active versican fragments that regulate interdigital web regression. Dev Cell, 2009 ; 17 : 687-98.
6) Burd A, Huang L : Hypertrophic response and keloid diathesis : two very different forms of scar. Plast Reconstr Surg, 2005 ; 116 : 150e-157e.
19) Dalkowski A, Schuppan D, Orfanos CE, et al : Increased expression of tenascin C by keloids in vivo and in vitro. Br J Dermatol, 1999 ; 141 : 50-6.
27) Sayani K, Dodd CM, Nedelec B, et al : Delayed appearance of decorin in healing burn scars. Histopathology, 2000 ; 36 : 262-72.
References_xml – reference: 10) Aoki M, Miyake K, Ogawa R, et al : siRNA Knockdown of Tissue Inhibitor of Metalloproteinase-1 in Keloid Fibroblasts Leads to Degradation of Collagen Type I. J Invest Dermatol, 2013 Sep 16. doi : 10. 1038/jid. 2013. 396.
– reference: 21) Yagi Y, Muroga E, Naitoh M, et al : An ex vivo model employing keloid-derived cell-seeded collagen sponges for therapy development. J Invest Dermatol, 2013 ; 133 : 386-93.
– reference: 9) Ulrich D, Ulrich F, Unglaub F, et al : Matrix metalloproteinases and tissue inhibitors of metalloproteinases in patients with different types of scars and keloids. J Plast Reconstr Aesthet Surg, 2010 ; 63 : 1015-21.
– reference: 8) Neely AN, Clendening CE, Gardner J, et al : Gelatinase activity in keloids and hypertrophic scars. Wound Repair Regen, 1999 ; 7 : 166-71.
– reference: 15) Amadeu TP, Braune AS, Porto LC, et al : Fibrillin-1 and elastin are differentially expressed in hypertrophic scars and keloids. Wound Repair Regen, 2004 ; 12 : 169-74.
– reference: 12) Meran S, Thomas DW, Stephens P, et al : Hyaluronan facilitates transforming growth factor-beta1-mediated fibroblast proliferation. J Biol Chem, 2008 ; 283 : 6530-45.
– reference: 26) Meenakshi J, Vidyameenakshi S, Ananthram D, et al : Low decorin expression along with inherent activation of ERK1, 2 in ear lobe keloids. Burns, 2009 ; 35 : 519-26.
– reference: 18) Kischer CW, Wagner HN Jr, Pindur J, et al : Increased fibronectin production by cell lines from hypertrophic scar and keloid. Connect Tissue Res, 1989 ; 23 : 279-88.
– reference: 23) Enomoto H, Nelson CM, Somerville RP, et al : Cooperation of two ADAMTS metalloproteases in closure of the mouse palate identifies a requirement for versican proteolysis in regulating palatal mesenchyme proliferation. Development, 2010 ; 137 : 4029-38.
– reference: 25) Honardoust D, Eslami A, Larjava H, et al : Localization of small leucine-rich proteoglycans and transforming growth factor-beta in human oral mucosal wound healing. Wound Repair Regen, 2008 ; 16 : 814-23.
– reference: 11) Phan TT, Lim IJ, Aalami O, et al : Smad3 signaling plays an important role in keloid pathogenesis via epithelial-mesenchymal interaction. J Pathol, 2005 ; 207 : 232-42.
– reference: 1) Smith LT, Holbrook KA, Madri JA : Collagen types I, III, and V in human embryonic and fetal skin. Am J Anat, 1986; 175 : 507-21.
– reference: 6) Burd A, Huang L : Hypertrophic response and keloid diathesis : two very different forms of scar. Plast Reconstr Surg, 2005 ; 116 : 150e-157e.
– reference: 7) Khasigov PZ, Podobed OV, Ktzoeva SA, et al : Matrix metalloproteinases of normal human tissues. Biochemistry (Mosc), 2001 ; 66 : 130-40.
– reference: 16) Babu M, Diegelmann R, Oliver N : Fibronectin is overproduced by keloid fibroblasts during abnormal wound healing. Mol Cell Biol, 1989 ; 9 : 1642-50.
– reference: 27) Sayani K, Dodd CM, Nedelec B, et al : Delayed appearance of decorin in healing burn scars. Histopathology, 2000 ; 36 : 262-72.
– reference: 19) Dalkowski A, Schuppan D, Orfanos CE, et al : Increased expression of tenascin C by keloids in vivo and in vitro. Br J Dermatol, 1999 ; 141 : 50-6.
– reference: 22) McCulloch DR, Nelson CM, Dixon LJ, et al : ADAMTS metalloproteases generate active versican fragments that regulate interdigital web regression. Dev Cell, 2009 ; 17 : 687-98.
– reference: 17) Kischer CW, Hendrix MJ : Fibronectin (FN) in hypertrophic scars and keloids. Cell Tissue Res, 1983 ; 231 : 29-37.
– reference: 4) Luo S, Benathan M, Raffoul W, et al : Abnormal balance between proliferation and apoptotic cell death in fibroblasts derived from keloid lesions. Plast Reconstr Surg, 2001 ; 107 : 87-96.
– reference: 2) Bran GM, Goessler UR, Hormann K, et al : Keloids : Current concepts of pathogenesis (review). Int J Mol Med, 2009 ; 24 : 283-93.
– reference: 13) Meyer LJ, Russell SB, Russell JD, et al : Reduced hyaluronan in keloid tissue and cultured keloid fibroblasts. J Invest Dermatol, 2000 ; 114 : 953-9.
– reference: 20) Sible JC, Retting WJ, Eriksson E, et al : Gene expression of tenascin is altered in normal scars and keloids. Wound Repair Regen, 1995 ; 3 : 37-48.
– reference: 14) Ikeda M, Naitoh M, Kubota H, et al : Elastic fiber assembly is disrupted by excessive accumulation of chondroitin sulfate in the human dermal fibrotic disease, keloid. Biochem Biophys Res Commun, 2009 ; 390 : 1221-8.
– reference: 5) Sasaki T, Majamaa K, Uitto J : Reduction of collagen production in keloid fibroblast cultures by ethyl-3, 4-dihydroxybenzoate. Inhibition of prolyl hydroxylase activity as a mechanism of action. J Biol Chem, 1987 ; 262 : 9397-403.
– reference: 3) Chodon T, Sugihara T, Igawa HH, et al : Keloid-derived fibroblasts are refractory to Fas-mediated apoptosis and neutralization of autocrine transforming growth factor-β1 can abrogate this resistance. Am J Pathol, 2000 ; 157 : 1661-9.
– reference: 24) 荒牧典子, 磯貝善蔵, 岡部圭介, ほか : ケロイド組織における細胞外マトリックスの産生・分解. 瘢痕・ケロイド治療ジャーナル, 2013 ; 7 : 5-7.
SSID ssib004648371
ssj0000400192
Score 1.592173
Snippet ...
SourceID jstage
SourceType Publisher
StartPage 51
SubjectTerms ケロイド
コラーゲン
バーシカン
細胞外マトリックス
Title 細胞外マトリックスから見たケロイド
URI https://www.jstage.jst.go.jp/article/jsswc/5/2/5_51/_article/-char/ja
Volume 5
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX 創傷, 2014, Vol.5(2), pp.51-55
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Na9RAFA-1XrxIRcVvenBOknUnmUlmjpPdLEVBEFrYW0gyyWEPVeyWgrcmF0vvPdZL8SCICl78ewaxf4bvTT42fhxqYTc83r75zZt52bz3hpkXx3lc5hnT40K7OfNTl4Vcu5kuArfMREqZZmme2WqfL4KtHfZszudrV6rBrqX9ZTbK3_7zXMllrAo8sCuekv0Py_agwAAa7AtXsDBcL2RjEockYiQak1gQ4RMZk5gTxYgMSOx3HEsI0RJKdRzfEh5Rs5aIpCUoEVHLERKRVdBxKJG9MO0Apx0O65DlMORFlQAn4paAhr3nQ_WVb_sXJPKInKLBUQz0Fwy5EkbHV_JWDEYMItGMYHXfVh5UnSAcyMvZSp6jvAJNpdVU9PITqzaARzC0Ib6YIhgggcqqxxcAJOzcws_j4UoJXa2RWjyBW0cQB6bNagSzElmzyAgHGwckArNwK6zg8wRZMBLFLTGxzf6csYFZQ1RL0lYZMA0CTYhsy7g2_kUI5sIjcz50QHzwP_MGzqStxNuEJU0x478dHoTn6PH29g7yER91TX6rIN7en4kVSnjiwZfTpGPj8b5kATnGVS8MKW6Lff5yEK8E-M4B2q9b4kMfsoL2qCt2_3TVOYRxC0hqug2RNkbb3nCut8nVpmq6vOGsLdKbjv_z25fz-vTH2YmpT039ztQfTV2b6rOpvpvDY1MdnX84NofvTfXV1J9MdWbqo1vOzizenmy57atC3IWHuxNYriETL3UaeCVk8Lmk4RgeQSm4mDLzwjIPx4UIQw1yuY8vutU6CDymfZ0H3CsD_7azvvtqt7jjbJZhxgo8vUalZhDRZgVLATyVkOj7oqR3Hd6MMXnd1INJLja_9y7Z7r5zDW_mZtnvgbO-fLNfPIRAeJk9spb6BX1tjyU
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=%E7%B4%B0%E8%83%9E%E5%A4%96%E3%83%9E%E3%83%88%E3%83%AA%E3%83%83%E3%82%AF%E3%82%B9%E3%81%8B%E3%82%89%E8%A6%8B%E3%81%9F%E3%82%B1%E3%83%AD%E3%82%A4%E3%83%89&rft.jtitle=%E5%89%B5%E5%82%B7&rft.au=%E7%A3%AF%E8%B2%9D%2C+%E5%96%84%E8%94%B5&rft.au=%E8%B2%B4%E5%BF%97%2C+%E5%92%8C%E7%94%9F&rft.au=%E5%B2%A1%E9%83%A8%2C+%E5%9C%AD%E4%BB%8B&rft.au=%E8%8D%92%E7%89%A7%2C+%E5%85%B8%E5%AD%90&rft.date=2014&rft.pub=%E4%B8%80%E8%88%AC%E7%A4%BE%E5%9B%A3%E6%B3%95%E4%BA%BA+%E6%97%A5%E6%9C%AC%E5%89%B5%E5%82%B7%E5%A4%96%E7%A7%91%E5%AD%A6%E4%BC%9A&rft.eissn=1884-880X&rft.volume=5&rft.issue=2&rft.spage=51&rft.epage=55&rft_id=info:doi/10.11310%2Fjsswc.5.51&rft.externalDocID=article_jsswc_5_2_5_51_article_char_ja